Skip to content

Assessment of drug response in each Sasang typology by evaluating intestinal microbiota and intestinal permeability in obese patients

Assessment of drug response in each Sasang typology by evaluating intestinal microbiota and intestinal permeability in obese patients: A Randomized, Double-blind Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000650
Enrollment
120
Registered
2013-01-31
Start date
2011-10-24
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : randomized participants were prescribed to either Ginseng, Rehmanniae Radix or Ephedrae herba extract granule to administer twice a day at each visit for total 8 weeks.

Sponsors

Dongguk University Ilsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among all men and women aged between 19 and 65 years who meet the criteria of BMI>23kg/m2

Exclusion criteria

Exclusion criteria: 1)women with any condition that can affect weight gain such as hypothyroidism, cushing syndrome 2)heart disease(heart failure, angina pectoris, myocardial infarction) 3)cancer or lung disease 4)liver dysfunction(ALT, AST = 2.5 fold upper limit of normal) 5)women who are diagnosed with cholelithiasis 6)severe renal dysfunction (Cr >2.0mg/dl) 7)Narrow angle glaucoma 8)neuropsychiatric diseases(schizophrenia, epilepsy, alcoholism, drug addiction, anorexia nervosa, hyperphagia) 9)past history of stroke, transient ischemic heart disease 10)eating disorder such as anorexia nervosa and bulimia nervosa 11)women who have taken anorexiants, relievers(without prescription), oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine, or any other medication within 3 months that can affect absorption, metabolism, excretion which can affect on weight. 12)who are on narcotics and neuropsychological drugs for weight reduction 13)other forbidden treatments(insulin, hypogycemic agents, antidepressants, anti serotonin reuptake inhibitor, sodium pentobarbital, antipsychotics, drugs concerned with misuse) 14)women who underwent anatomical change such as incision which makes it difficult to conduct physical measurements 15)women who underwent surgeries for weiight reduction(gastroplastia) 16)pregnant women, breast feeder, women planning a pregnancy and those who do not agree to use adequate contraception such as oral contraceptives, hormone transplant, IUD, spermicide, condom, celibacy. 17)women who have taken other medications provided by clinical trial within a month 18)women who have lost more than 10% of body weight within 6 months 19)women who are judged to be unacceptable for candidate by person in charge of clinical trial 20)women who have given up on smoking within past 3 months but who have irregular smoking habit

Design outcomes

Primary

MeasureTime frame
difference of intestinal microbiota ratio according to Sasang typology and herbal medicine group;difference of intestinal permeability (Lactulose mannitol ratio) according to Sasang typology and herbal medicine group

Secondary

MeasureTime frame
weight;body composition (body fat mass, muscle mass);blood lipid profile (triglyceride, total cholesterol, HDL cholesterol);waist circumference;blood pressure;blood glucose;BMI (Body mass index)

Countries

Korea, Republic of

Contacts

Public ContactHojun Kim

Dongguk University Ilsan Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026